Preliminary Safety Results from the Phase IIIb GREEN Study of Obinutuzumab (GA101) Alone or in Combination with Chemotherapy for Previously Untreated or Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Bosch, Francesc; Illmer, Thomas; Turgut, Mehmet; Cortelezzi, Agostino; Lasserre, Susan F.; Truppel-Hartmann, Anna; Stilgenbauer, Stephan

doi:10.1182/blood.V124.21.3345.3345

Publication:
Preliminary Safety Results from the Phase IIIb GREEN Study of Obinutuzumab (GA101) Alone or in Combination with Chemotherapy for Previously Untreated or Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

dc.contributor.author	Bosch, Francesc
dc.contributor.author	Illmer, Thomas
dc.contributor.author	Turgut, Mehmet
dc.contributor.author	Cortelezzi, Agostino
dc.contributor.author	Lasserre, Susan F.
dc.contributor.author	Truppel-Hartmann, Anna
dc.contributor.author	Stilgenbauer, Stephan
dc.contributor.authorID	Bosch, Francesc/0000-0001-9241-2886
dc.date.accessioned	2020-06-21T13:52:10Z
dc.date.available	2020-06-21T13:52:10Z
dc.date.issued	2014
dc.department	OMÜ	en_US
dc.department-temp	[Bosch, Francesc] Univ Hosp Vall dHebron, Barcelona, Spain -- [Illmer, Thomas] Oncol Practice Dresden, Dresden, Germany -- [Turgut, Mehmet] Ondokuz Mayis Univ, Samsun, Turkey -- [Cortelezzi, Agostino] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy -- [Cortelezzi, Agostino] Univ Milan, Milan, Italy -- [Lasserre, Susan F. -- Truppel-Hartmann, Anna] F Hoffmann La Roche Ltd, Basel, Switzerland	en_US
dc.description	56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA	en_US
dc.description.abstract	…	en_US
dc.description.sponsorship	Amer Soc Hematol	en_US
dc.identifier.doi	10.1182/blood.V124.21.3345.3345
dc.identifier.issn	0006-4971
dc.identifier.issn	1528-0020
dc.identifier.issue	21	en_US
dc.identifier.uri	https://doi.org/10.1182/blood.V124.21.3345.3345
dc.identifier.uri	https://hdl.handle.net/20.500.12712/14833
dc.identifier.volume	124	en_US
dc.identifier.wos	WOS:000349233802079
dc.language.iso	en	en_US
dc.publisher	Amer Soc Hematology	en_US
dc.relation.journal	Blood	en_US
dc.relation.publicationcategory	Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı	en_US
dc.rights	info:eu-repo/semantics/closedAccess	en_US
dc.title	Preliminary Safety Results from the Phase IIIb GREEN Study of Obinutuzumab (GA101) Alone or in Combination with Chemotherapy for Previously Untreated or Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)	en_US
dc.type	Conference Object	en_US
dspace.entity.type	Publication

Collections

WoS İndeksli Yayınlar Koleksiyonu

Publication: Preliminary Safety Results from the Phase IIIb GREEN Study of Obinutuzumab (GA101) Alone or in Combination with Chemotherapy for Previously Untreated or Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Files

Collections

Publication:
Preliminary Safety Results from the Phase IIIb GREEN Study of Obinutuzumab (GA101) Alone or in Combination with Chemotherapy for Previously Untreated or Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)